Renal cell carcinoma: A model system for novel drug development?

被引:2
作者
Bukowski, Ronald M. [1 ]
机构
[1] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Taussig Canc Ctr, Cleveland, OH 44106 USA
关键词
D O I
10.3816/CGC.2008.n.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:7 / 8
页数:2
相关论文
共 12 条
[1]   Factors associated with outcome in patients with advanced renal cell carcinoma in the era of Antiangiogenic agents [J].
Choueiri, Toni K. .
CLINICAL GENITOURINARY CANCER, 2008, 6 (01) :15-20
[2]   RETRACTED: Immunotherapy for advanced renal cell cancer - art. no. CD001425.pub2 (Retracted Article) [J].
Coppin, C ;
Porzsolt, F ;
Awa, A ;
Kumpf, J ;
Coldman, A ;
Wilt, T .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[3]   Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].
Escudier, Bernard ;
Pluzanska, Anna ;
Koralewski, Piotr ;
Ravaud, Alain ;
Bracarda, Sergio ;
Szczylik, Cezary ;
Chevreau, Christine ;
Filipek, Marek ;
Melichar, Bohuslav ;
Bajetta, Emilio ;
Gorbunova, Vera ;
Bay, Jacques-Olivier ;
Bodrogi, Istvan ;
Jagiello-Gruszfeld, Agnieszka ;
Moore, Nicola .
LANCET, 2007, 370 (9605) :2103-2111
[4]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[5]   Phase II trial of pegylated interferion-α2b in patients with advanced renal cell carcinoma [J].
Feldman, Darren R. ;
Kondagunta, G. Varuni ;
Schwartz, Lawrence ;
Patil, Sujata ;
Ishill, Nicole ;
DeLuca, John ;
Russo, Paul ;
Motzer, Robert J. .
CLINICAL GENITOURINARY CANCER, 2008, 6 (01) :25-30
[6]   Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma [J].
Hudes, Gary ;
Carducci, Michael ;
Tomczak, Piotr ;
Dutcher, Janice ;
Figlin, Robert ;
Kapoor, Anil ;
Staroslawska, Elzbieta ;
Sosman, Jeffrey ;
McDermott, David ;
Bodrogi, Istvan ;
Kovacevic, Zoran ;
Lesovoy, Vladimir ;
Schmidt-Wolf, Ingo G. H. ;
Barbarash, Olga ;
Gokmen, Erhan ;
O'Toole, Timothy ;
Lustgarten, Stephanie ;
Moore, Laurence ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2271-2281
[7]  
HUTSON TE, 2007, J CLIN ONCOL, V25, pS242
[8]   A university of chicago consortium phase II trial of SB-715992 in advanced renal cell cancer [J].
Lee, Richard T. ;
Beekman, Kathleen E. ;
Hussain, Maha ;
Davis, Nancy B. ;
Clark, Joseph I. ;
Thomas, Sachdev P. ;
Nichols, Katherine F. ;
Stadler, Walter M. .
CLINICAL GENITOURINARY CANCER, 2008, 6 (01) :21-24
[9]   Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Rixe, Olivier ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Kim, Sindy T. ;
Chen, Isan ;
Bycott, Paul W. ;
Baum, Charles M. ;
Figlin, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124
[10]   Phase II placebo-controlled randomized discontinuation trial of sorafnib in patients with metastatic renal cell carcinoma [J].
Ratain, Mark J. ;
Eisen, Tim ;
Stadler, Walter M. ;
Flaherty, Keith T. ;
Kaye, Stan B. ;
Rosner, Gary L. ;
Gore, Martin ;
Desai, Apurva A. ;
Patnaik, Amita ;
Xiong, Henry Q. ;
Rowinsky, Lric ;
Abbruzzese, James L. ;
Xia, Chenghua ;
Simantov, Ronit ;
Schwartz, Brian ;
O'Dwyer, Peter J. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (16) :2505-2512